METHOD FOR PREPARING LEVULINIC ACID USING SOLID ACID CATALYST IN PRESENCE OF ETHYLENE GLYCOL-BASED COMPOUND SOLVENT DERIVED FROM BIOMASS
申请人:KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY
公开号:US20160221908A1
公开(公告)日:2016-08-04
Provided is a method for preparing levulinic acid using a solid acid catalyst in the presence of an ethylene glycol-based compound. The levulinic acid according to the present invention can be prepared by using a linear or cyclic ethylene glycol-based compound as a solvent and preparing the levulinic acid from fructose in the presence of the solid acid catalyst at a reaction temperature of 100 to 200° C., thereby reducing the dependency on petroleum in response to greenhouse gas emission regulations. Also, a high yield of levulinic acid can be obtained from fructose, and the solvent and the catalyst can be efficiently separated, collected, and reused after the reaction has completed.
METHOD FOR PREPARING 5-HYDROXYMETHYL-2-FURFURAL USING ACID CATALYST IN PRESENCE OF ETHYLENE GLYCOL-BASED COMPOUND SOLVENT DERIVED FROM BIOMASS
申请人:KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY
公开号:US20160207896A1
公开(公告)日:2016-07-21
Provided is a method for preparing 5-hydroxymethyl-2-furfural using an acid catalyst in the presence of an ethylene glycol-based solvent. The method for preparing the 5-hydroxymethyl-2-furfural involves using a linear or cyclic ethylene glycol-based compound as a solvent and producing the 5-hydroxymethyl-2-furfural from fructose, in the presence of the acid catalyst, thereby reducing the dependency on petroleum in response to greenhouse gas emission regulations. Also, a high yield of the 5-hydroxymethyl-2-furfural can be obtained from fructose, and the solvent and the catalyst can be efficiently separated, collected, and reused after a reaction has completed.
COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE
申请人:Thorson Jon S.
公开号:US20130012466A1
公开(公告)日:2013-01-10
Colchicine neoglycosides, method for their synthesis and methods for their use are disclosed. The invention provides analogs of colchicine glycosylated to include a sugar moiety on a colchicine scaffold that is generally unglycosylated in nature. The colchicine neoglycosides disclosed herein are shown to have cytotoxic effects equivalent to at least the known cytotoxins paclitaxel and doxorubicin. Further, the neoglycosides disclosed according to the invention have physiologic effects not previously recognized in the alkaloid family that includes colchicine but recognized in other cytotoxic drug families such as the taxanes which act by stabilizing tubulin formation.